ArticleParasitology research1987
Inhibition of the adhesion of Entamoeba histolytica trophozoites to human erythrocytes by carbohydrates.
Article in Parasitology research, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 22 citations in OpenAlex.
- Selected Protective Mechanisms of Human Milk Against Intestinal Protozoal Infections in Infants.Current issues in molecular biology · 2025Review
- The Role of Maternal Breast Milk in Preventing Infantile Diarrhea in the Developing World.Current tropical medicine reports · 2014Article
- Human milk oligosaccharides: every baby needs a sugar mama.Glycobiology · 2012Review
- Structure-function relationships of human milk oligosaccharides.Advances in nutrition (Bethesda, Md.) · 2012Review
- The invasiveness of Entamoeba histolytica - a continuing enigma.Clinical molecular pathology · 1996Article
- Inhibitory activity of saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro.Parasitology research · 1994Article
- A new in vitro model of Entamoeba histolytica adhesion, using the human colon carcinoma cell line Caco-2: scanning electron microscopic study.Infection and immunity · 1991Article
- Specificity of glycosphingolipid recognition by Entamoeba histolytica trophozoites.Infection and immunity · 1990Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have analyzed the effect of 14 carbohydrates (seven monosaccharides, four disaccharides and three aminosugars) on the adhesion of Entamoeba histolytica HK9 trophozoites to human red blood cells (RBC). Amebal adhesion was significantly inhibited by five of these carbohydrates with the following order of potency: lactose (Lac) greater than N-acetylgalactosamine (GalNac) greater than melibiose (Mel) greater than galactose (Gal) greater than N-acetylglucosamine (GlcNAc). The mean inhibitory concentration of Lac was 2.66 mM. Adhesion increased by 20% in the presence of 5.5 mM glucose (Glc). Inhibition of the adhesion was lower in the absence rather than in the presence of Glc only with Gal-NAc, whereas it was similar with Lac, Mel, Gal, and GlcNAc in both cases. The initial rate of amebal adhesion decreased 27% by RBC fixation, but adhesion to fixed RBC was also inhibited by the same five carbohydrates. Inhibition was higher in mixtures containing Lac, GalNAc, and Mel, than with the same isolated carbohydrates; Lac + Gal-NAc was the most potent mixture. Inhibition decreased when Lac, GalNAc, and Mel were mixed either with Gal or GlcNAc. We conclude that E. histolytica adhesion depends on amebal metabolic energy generated from Glc and on several surface components of RBC, some of which are inactivated with glutaraldehyde whereas others are inhibited by sugars containing Gal, GlcNAc, or Gal-NAc residues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.